Core Insights - PetVivo Holdings, Inc. will exhibit at the Veterinary Meeting & Expo Conference from January 25th to January 29th, 2025, in Orlando, Florida [1] - The company will showcase its lead product, Spryng with OsteoCushion Technology, which is designed to manage joint pain in animals [2][7] - The VMX Conference is the largest veterinary conference in the U.S., attracting top industry professionals [3] Product Information - Spryng is an intra-articular injectable veterinary medical device made of sterilized, extra-cellular matrix microparticles that integrate with the animal's subsynovial tissue [2] - The product aims to restore proper joint mechanics and manage noninfectious joint pain sources, including joint instability, degenerative joint disease, and osteoarthritis [2][7] Company Overview - PetVivo Holdings focuses on the manufacturing, commercialization, and licensing of innovative medical devices and therapeutics for companion animals [6] - The company has developed a robust pipeline of products and holds a portfolio of 21 patents protecting its biomaterials and methods of use [7] - PetVivo's strategy includes developing human therapies for companion animals in a capital and time-efficient manner, allowing for quicker market entry compared to human pharmaceuticals [6]
PetVivo to Exhibit Spryng with OsteoCushion™ Technology at the Veterinary Meeting and Expo Conference in Orlando, Florida on January 25-29, 2025